Drug Assignments

 

Drug Name
Active Ingred
Mfr
Indication
Approval
Date
AHFS Class
NDA
Chem
Type*
Appl No
Abilify Mycite® aripiprazole with ingestible event marker (IEM) Otsuka schizophrenia, bipolar disorder, major depressive disorder 2017/11/13 28:16.08.04 - Atypical Antipsychotics 4 207202
Admelog® insulin lispro Sanofi Aventis diabetes mellitus 2017/12/11 68:20.08 - Insulins 5S 209196
Adzenys® ER amphetamine Neos attention deficit hyperactivity disorder (ADHD) 2017/09/15 28:20.04 - Amphetamines 3S 204325
AirDuoTM Respiclick® fluticasone propionate; salmeterol Teva asthma 2017/01/27 68:04 - Adrenals; 12:12.08.12 - Selective beta-2-Adrenergic Agonists 4S 208799
Aliqopa® copanlisib Bayer relapsed follicular lymphoma (FL) 2017/09/14 10:00 - Antineoplastic Agents 1P/O 209936
Altafluor Benox® fluorescein; benoxinate Altaire tonometry, gonioscopy 2017/12/14 36:58 - Ocular Disorders; 52:16 - Local Anesthetics 4P 208582
Alunbrig® brigatinib Ariad anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) 2017/04/28 10:00 - Antineoplastic Agents 1P 208772
ArmonAirTM Respiclick® fluticasone propionate Teva asthma 2017/01/27 68:04 - Adrenals 5S 208798
Arymo ER® morphine sulfate Egalet severe pain requiring daily, around-the-clock, long-term opioid treatment 2017/01/09 28:08.08 - Opiate Agonists 5S 208603
Ascor® ascorbic acid McGuff scurvy 2017/10/02 88:12 - Vitamin C 7S 209112
Showing 1 to 10 of 118 entries

Drug Classification Changes

 

AHFS Class
Change Date
Change Description
26:00 - Cellular and Gene Therapy 2017/09/08 Rename class from Cellular Therapy
26:04 - Cellular Therapy 2017/09/08 New subclass
26:12 - Gene Therapy 2017/09/08 New subclass
28:56 - Vesicular Monoamine Transporter 2 (VMAT2) Inhibitors 2017/10/16 New subclass
68:16.08 - Antiestrogens 2017/09/20 Revived old class that was retired in 2007
68:18 - Gonadotropins and Antigonadotropins 2017/09/15 Rename class from Gonadotropins
68:18.04 - Antigonadotropins 2017/09/15 New subclass
68:18.08 - Gonadotropins 2017/09/15 New subclass
68:24 - Parathyroid and Antiparathyroid Agents 2017/08/10 Rename class from Parathyroid
68:24.04 - Antiparathyroid Agents 2017/08/10 New subclass
Showing 1 to 10 of 16 entries

Drug Reassignments

 

Drug Name(s)
Active Ingred
Change
Date
Old AHFS Class
New AHFS Class
Aclovate® alclometasone 2017/12/15 84:06 - Anti-inflammatory Agents 84:06.08 - Corticosteroids
Ala-Cort®, Anucort-HC®, Anusert-HC®, Anusol-HC®, Cetacort®, Cortizone®, Dermacort®, Lanacort®, Proctocort®, Sarnol-HC®, Texacort®, Westcort® hydrocortisone 2017/12/15 84:06 - Anti-inflammatory Agents 84:06.08 - Corticosteroids
Alphatrex®, Betatrex®, Beta-Val®, Diprolene®, Luxiq®, Maxivate® betamethasone 2017/12/15 84:06 - Anti-inflammatory Agents 84:06.08 - Corticosteroids
Antagon® ganirelix 2017/09/15 92:40 - Gonadotropin-releasing Hormone Antagonists 68:18.04 - Antigonadotropins
Arimidex® anastrozole 2017/09/20 10:00 - Antineoplastic Agents 68:16.08 - Antiestrogens; 10:00 - Antineoplastic Agents
Aristocort®, Flutex®, Kenalog®, Triacet® triamcinolone 2017/12/15 84:06 - Anti-inflammatory Agents 84:06.08 - Corticosteroids
Aromsin® exemestane 2017/09/20 10:00 - Antineoplastic Agents 68:16.08 - Antiestrogens; 10:00 - Antineoplastic Agents
Austedo® deutetrabenazine 2017/10/16 28:92 - CNS Agents, Misc 28:56 - Vesicular Monoamine Transporter 2 (VMAT2) Inhibitors
Capex®, Derma-Smoothe/FS®, Lidex®, Lidex-E®, Synalar®, Synemol® fluocinolone/fluocinonide 2017/12/15 84:06 - Anti-inflammatory Agents 84:06.08 - Corticosteroids
Cetrotide® cetrorelix 2017/09/15 92:40 - Gonadotropin-releasing Hormone Antagonists 68:18.04 - Antigonadotropins
Showing 1 to 10 of 51 entries